The FDA’s decision to pause the rollout of the Johnson & Johnson vaccine sparked criticism from across the spectrum that the administration was being too cautious.
President Joe Biden pledged to maintain an unwavering fidelity to science since the Covid-19 pandemic first emerged in the United States, again and again citing it as his North Star in navigating the deadly virus.
That strategy had mostly gone off without a major snag — until now.
On Tuesday, the government’s own scientists recommended a pause in administering the single-dose Johnson & Johnson vaccine, amid reports that a handful of patients had developed serious blood clots that may be linked to it. The White House embraced the decision and officials on Tuesday expressed hope the pace of vaccinations would not slow down, insisting that there were plenty of Pfizer and Moderna vaccines to meet an administration goal of having enough vaccine supply for every U.S. adult by May 31.
DONATE TO BIZPAC REVIEW
Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!
- The Florida candidate laser-focused on eradicating horrific animal crimes - March 22, 2024
- Sabo: ‘Rush was our GOAT, there was no equal and he made it look easy’ - February 18, 2024
- Dana Bash appears to want to crawl out of her own skin when Ramaswamy ‘goes there’ on J6 - December 7, 2023
Comment
We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.
BPR INSIDER COMMENTS
Scroll down for non-member comments or join our insider conversations by becoming a member. We'd love to have you!
